Cleared Traditional

K110334 - WALDO PATIENT MONITOR

K110334 is an FDA 510(k) clearance for WALDO PATIENT MONITOR, manufactured by Waldo Health. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 67-day FDA review.

K110334 · Waldo Health · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2011
Decision
67d
Days
Class 2
Risk

K110334 is an FDA 510(k) clearance for the WALDO PATIENT MONITOR. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Waldo Health (Austin, US). The FDA issued a Cleared decision on April 12, 2011 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Waldo Health devices

FDA 510(k) Submission Details - K110334

510(k) Number K110334 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 04, 2011
Decision Date April 12, 2011
Days to Decision 67 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 125d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 178
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K110334.
ASCOT HOME MEDICAL MONITORING SYSTEM (HMMS)
K103643 · Ascot Technologies, Inc. · Oct 2011
TELEMEDCARE HEALTH MONITOR
K103796 · Telemedcare Pty, Ltd. · Aug 2011
WIRELESS MONITORING SYSTEM
K110809 · Carefusion 303, Inc. · Jul 2011
INTEL HEALTH GUIDE
K103276 · Intel Corporation Digital Health Group · Feb 2011
NIHON KHDEN PREFENSE EDNS-9000 SERIES CENTRAL NURSE STATION
K102106 · Nihon Kohden Corp. · Dec 2010
M3810A PHILIPS TELEMONITORING SYSTEM WITH EDEVICE BRIDGED130
K103214 · Lifeline Systems, Inc. · Dec 2010